Punch & Associates Investment Management, Inc. Abb Vie Inc. Transaction History

Punch & Associates Investment Management, Inc.

$1.68 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$137.6 - $154.97 $309,600 - $348,682	2,250 New	2,250 $348,000
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $86,833 - $100,522	650 Added 40.63%	2,250 $335,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $242,042 - $290,272	-1,750 Reduced 52.24%	1,600 $258,000
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $1,064 - $1,207	-10 Reduced 0.3%	3,350 $361,000
Q1 2021 May 18, 2021	SELL	$102.3 - $112.62 $6,444 - $7,095	-63 Reduced 1.84%	3,360 $364,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $5,070 - $6,846	63 Added 1.88%	3,423 $367,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $733 - $981	10 Added 0.3%	3,360 $330,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $216,075 - $327,596	3,350 New	3,350 $255,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.

Account